Advertisement

Topics

Symbiomix Therapeutics, LLC Company Profile

14:49 EST 18th November 2017 | BioPortfolio

Symbiomix (sim-bye-OH-mix) is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections that can have serious health consequences. The Company’s lead investigational drug Solosec™ (secnidazole) oral granules, a potent, next-generation 5-nitroimidazole antibiotic, is anticipated to be the first and only single-dose oral treatment approved for bacterial vaginosis (BV). Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world’s leading healthcare venture capital firms: OrbiMed, F-Prime Capital Partners, and HBM Partners. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut. Please visit https://symbiomix.com/ and follow the Company on LinkedIn and Twitter for more information.


News Articles [534 Associated News Articles listed on BioPortfolio]

FDA approves Symbiomix Therapeutics’ Solosec for bacterial vaginosis

Symbiomix Therapeutics announced the FDA has approved Solosec (secnidazole) 2g oral granules for the treatment of bacterial vaginosis (BV) in adult women. Solosec is a potent, next-generation, 5-nitro...

Lupin acquires Symbiomix Therapeutics

David SalazarLupin acquired the company for $150 million, bringing into its drug portfolio Symbiomix’s recently approved single-dose treatment for bacterial vaginosis.  read more

Lupin Primes For Specialty Future With Symbiomix Acquisition

Lupin has snapped up Symbiomix Therapeutics in the US as it gears to evolve it business from a straight generics...   

Lupin Coughs Up $150 Million Cash for This New Jersey-Based Biopharma

Lupin Acquires Symbiomix Therapeutics LLCMaterial Addition to Lupins Womens Health Care Portfolio with Newly Approved Solosec for Bacterial Vaginosis (BV) Mumbai, October 11, 2017: Pharma...

Symbiomix Therapeutics Receives FDA Approval of Solosec™ (secnidazole) Oral Granules Following Four-Year Collaboration with Catalent

Somerset, N.J. (PRWEB) October 02, 2017 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and...

Lupin Acquires Symbiomix Therapeutics for $150M

Lupin said today it has acquired Symbiomix Therapeutics for $150 million cash, in a deal designed to expand the buyer’s branded women’s health specialty drug business. In acquiring Symbiomix t...

FDA Approves Symbiomix Therapeutics’ Solosec (secnidazole) Oral Granules for the Treatment of Bacterial Vaginosis in Adult Women

NEWARK, N.J.--(BUSINESS WIRE) September 18, 2017 --Symbiomix Therapeutics today announced the U.S. Food and Drug Administration (FDA) has approved Solosec (secnidazole) 2g oral granules for the treatm...

Lupin scoops up women's health specialist Symbiomix for $150 million

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics for $150 million in a move to double down on its ...

Clinical Trials [120 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1169 Associated Companies listed on BioPortfolio]

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company with a focus on women’s health. Symbiomix is based in New Jersey, with additional offices...

Symbiomix Therapeutics, LLC

Symbiomix (sim-bye-OH-mix) is a biopharmaceutical company bringing innovative medicines to market for prevalent gynecological infections that can have serious health consequences....

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Symbiomix Therapeutics, LLC" on BioPortfolio

We have published hundreds of Symbiomix Therapeutics, LLC news stories on BioPortfolio along with dozens of Symbiomix Therapeutics, LLC Clinical Trials and PubMed Articles about Symbiomix Therapeutics, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Symbiomix Therapeutics, LLC Companies in our database. You can also find out about relevant Symbiomix Therapeutics, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record